1. Samuels A. The toxicity/safety of processed free glutamic acid (MSG): A study in suppression of information. Accountability in Research 1999; 6(4):259-310. [DOI via Crossref] [Pubmed] |
|
2. Ikeda K. On the taste of the salt of glutamic acid. J Tokyo Chem Soc 1909; 30:820-836. |
|
3. Leung A and Foster S. Encyclopedia of common natural ingredient used in food, drugs and cosmetics. New York: Wiley, pp. 373-375, 1996. |
|
4. Kwok RHM. The Chinese restaurant syndrome. N Engl J Med 1968; 207:796. |
|
5. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164:719-721. [DOI via Crossref] [Pubmed] |
|
6. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim 2000; 49(4):239-249. [DOI via Crossref] [Pubmed] |
|
7. Dolnikoff M, Martin-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord 2001; 25(3):426-433. [DOI via Crossref] [Pubmed] |
|
8. Hermanussen M and Tresguerres JA. Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis. J Perinat Med 2003; 31:489-495 [DOI via Crossref] [Pubmed] |
|
9. Hermanussen M, Garcia AP, Sunder M, Voigt M, Salazar V, Tresguerres JA. Obesity, voracity, and short stature, the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 2006; 60: 25-31. [DOI via Crossref] [Pubmed] |
|
10. Ohguro H, Katsushima H, Maruyama I, Maeda T, Yanagihashi S, Metoki T, Nakazawa M. A high dietary intake of sodium glutamate as flavoring (ajinomoto) causes gross changes in retinal morphology and function. Exp Eye Res. 2002; 75(3):307-315. [DOI via Crossref] |
|
11. Reif-Lehrer L, Bergenthal J, Hanninen L. Effects of monosodium glutamate on chick embryo retina in culture. Invest Ophthalmol 1975; 14:114-124. [Pubmed] |
|
12. Sisk DR, Kuwabara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch Clin Exp Ophthalmol 1985; 223(5):250-258. [DOI via Crossref] |
|
13. Chambille I, Serviere J. Neurotoxic effects of neonatal injections of monosodium L-glutamate (L-MSG) on the retinal ganglion cell layer of the golden hamster: anatomical and functional consequences on the circadian system. J Comp Neurol 1993; 338(1):67-82. [DOI via Crossref] [Pubmed] |
|
14. Katie K, Najman S, Cekiae S, Bojaniae V. Hypothalamic lesion in mice treated with monosodium glutamate. Arch Oncol 2001; 9:159-161. |
|
15. Cekićl S, Filipović M, Jović Z, Nešićl M, Pešić G, Ćirić Milan, et al. Histopathologic changes at the hypothalamic nucleus arcuatus and thyroid level in rats treated with monosodium glutamate. Acta Fac Med Naiss 2004; 21:89-94. |
|
16. Holzwarth-McBride MA, Hurst EM, Knigge KM. Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat Rec 1976; 186:185-196. [DOI via Crossref] [Pubmed] |
|
17. Miskowiak B, Partyka M. Effect of neonatal treatment with MSG (monosodium glutamate) on thyroid of the adult male rats. Histol Histopathol 1999; 14:63-67 [Pubmed] |
|
18. Redding TW, Schally AV, Arimura A, Wakabayashi I. Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 1971; 8:245-255. [DOI via Crossref] [Pubmed] |
|
19. Lechan RM, Albert LC, Jackso IMD. Synthesis of luteinizing hormone releasing factor and thyrotropin releasing factor in glutamate lesioned mice. Nature Lond 1976; 264:463-465. [DOI via Crossref] [Pubmed] |
|
20. Bakke JL, Lawrence N, Bennett J, Robinson S, Bowers CY. Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 1978; 26:220-228. [DOI via Crossref] [Pubmed] |
|
21. Dhindsa KS, Omran RG, Bhup R. Histological changes in the thyroid gland induced by monosodium glutamate in mice. Acta Anatomica 1981; 109:97-102. [DOI via Crossref] [Pubmed] |
|
22. Hu L, Fernstrom JD, Goldsmith PC. Exogenous glutamate enhances glutamate receptor subunit expression during selective neuronal injury in the ventral arcuate nucleus of postnatal mice. Neuroendocrinology 1998; 68(2):77-88. [DOI via Crossref] [Pubmed] |
|
23. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997; 273: E202-E206. [Pubmed] |
|
24. Strieker-Krongrad A, Beck B, Burlet C. Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. Eur J Pharmacol 1996; 295:27-34. [DOI via Crossref] |
|
25. Abdel-Dayem MM, Elgendy MS. Effects of chronic estradiol treatment on the thyroid gland structure and function of ovariectomized rats. BMC Research Notes 2009; 2:173. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
26. Thomas GA, William D, Mohr U, Dungworth DL, Capen CC. Changes in structure and function of the thyroid follicular cell. In: Pathobiology of the aging rat. ILSI Press, Washington, DC, pp. 269-283, 1992. |
|